Sponsor Pipeline

Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07476066 Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive… Relapsed/Refractory Aggressive B-Cell Lymphoma Not Yet Recruiting
Get alerts when Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free